SEC Filing Details
Document Details
Form
Filing Date
October 27, 2026
Document Date
October 27, 2026
Form Description
SCHEDULE 13G/A - Description
Filing Group
Other
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.